
Inotilone
CAS No. 906366-79-8
Inotilone( —— )
Catalog No. M27469 CAS No. 906366-79-8
Inotilone is a major component of Inonotus linteus, a traditional Chinese medical herb and can be used for research of metastatic lung cancer cells.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 105 | Get Quote |
![]() ![]() |
5MG | 151 | Get Quote |
![]() ![]() |
10MG | 280 | Get Quote |
![]() ![]() |
25MG | 471 | Get Quote |
![]() ![]() |
50MG | 683 | Get Quote |
![]() ![]() |
100MG | 954 | Get Quote |
![]() ![]() |
500MG | 1917 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameInotilone
-
NoteResearch use only, not for human use.
-
Brief DescriptionInotilone is a major component of Inonotus linteus, a traditional Chinese medical herb and can be used for research of metastatic lung cancer cells.
-
DescriptionInotilone is a major component of Inonotus linteus, a traditional Chinese medical herb and can be used for research of metastatic lung cancer cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorTubulin polymerization|Apoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number906366-79-8
-
Formula Weight218.21
-
Molecular FormulaC12H10O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(O/C1=C\c(cc2)cc(O)c2O)=CC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Liu CW, et al. CHM-1, a novel microtubule-destabilizing agent exhibits antitumor activity via inducing the expression of SIRT2 in human breast cancer cells. Chem Biol Interact. 2018 Jun 1;289:98-108.
molnova catalog



related products
-
JNJ 10191584 maleate
histamine H4 receptor silent antagonist
-
Scoparone
Extracted from A.scoparia Waldst.e Kit seeds;Store the product in sealed, cool and dry condition.
-
N-Deshydroxyethyl Da...
N-Deshydroxyethyl Dasatinib (N-Deshydroxyethyl BMS-354825) is a metabolite of Dasatinib, a dasatinib-based molecule that degrades ABL by binding to the IAP ligand via a linker to form SNIPER.